Second generation inhibitors of BCR-ABL for the treatment of imatinib- resistant chronic myeloid leukaemia | Nature Reviews Cancer
IJMS | Free Full-Text | Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update
A therapeutically targetable mechanism of BCR-ABL–independent imatinib resistance in chronic myeloid leukemia | Science Translational Medicine
Frontiers | BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
IJMS | Free Full-Text | Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update
Frontiers | Advances in the research of the mechanism of secondary resistance to imatinib in gastrointestinal stromal tumors
Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells | PLOS ONE
Detection of mutations in CML patients resistant to tyrosine kinase inhibitor: imatinib mesylate therapy | SpringerLink
Deubiquitylation of Rab35 by USP32 promotes the transmission of imatinib resistance by enhancing exosome secretion in gastrointestinal stromal tumours | Oncogene
Bcr-Abl tyrosine-kinase inhibitor - Wikipedia
Mechanisms of acquired resistance to tyrosine kinase inhibitors - ScienceDirect
Cancers | Free Full-Text | Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance
Towards a Molecular Understanding of the Link between Imatinib Resistance and Kinase Conformational Dynamics | PLOS Computational Biology
Targeting SOS1 overcomes imatinib resistance with BCR-ABL independence through uptake transporter SLC22A4 in CML: Molecular Therapy - Oncolytics
Managing resistance in chronic myeloid leukemia. | Semantic Scholar
Mechanisms of resistance towards imatinib. (a) Imatinib is available... | Download Scientific Diagram
Bcr-Abl and Imatinib (STI571 or Gleevec) - Proteopedia, life in 3D
Imatinib Resistance Mutation Analysis - Kinase Domain Test in Delhi | GDIC
Imatinib - Wikipedia
Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. | Australian Medical Student Journal
Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia. | Semantic Scholar
Mechanisms of CML cells resistance to TKI. BCR-ABL dependent mechanisms... | Download Scientific Diagram
Imatinib Resistance and Progression of CML to Blast Crisis: Somatic Hypermutation AIDing the Way - ScienceDirect
Mechanisms of imatinib resistance in CML. Clinical imatinib resistance... | Download Scientific Diagram
![PDF] Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0a9b23d5cd08b70bab6df94e2948ce56a8452958/6-Figure1-1.png "PDF] Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia | Semantic Scholar")